tiprankstipranks
Trending News
More News >
Spero Therapeutics Inc (SPRO)
NASDAQ:SPRO
US Market
Advertisement

Spero Therapeutics (SPRO) Income Statement

Compare
568 Followers

Spero Therapeutics Income Statement

Last quarter (Q2 2025), Spero Therapeutics's total revenue was $14.19M, an increase of 135.82% from the same quarter last year. In Q2, Spero Therapeutics's net income was $0.00. See Spero Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 27.40M$ 96.73M$ 48.58M$ 18.26M$ 9.33M
Gross Profit
$ 27.39M$ 96.37M$ 5.92M$ 17.14M$ -57.67M
Operating Expenses
$ 100.76M$ 75.25M$ 48.11M$ 91.04M$ 88.44M
Depreciation and Amortization
$ 2.00K$ 367.00K$ 1.55M$ 646.00K$ 1.35M
EBITDA
$ -72.48M$ 25.77M$ -42.26M$ -87.17M$ -76.93M
Operating Income
$ -73.36M$ 21.48M$ -42.20M$ -87.97M$ -79.11M
Other Income/Expenses
$ 4.79M$ 3.92M$ -4.22M$ -1.78M$ 833.00K
Pretax Income
$ -68.57M$ 25.40M$ -46.41M$ -89.76M$ -78.28M
Net Income
$ -68.57M$ 22.81M$ -46.41M$ -89.76M$ -78.28M
Per Share Metrics
Basic EPS
$ -1.27$ 0.43$ -1.23$ -2.91$ -3.52
Diluted EPS
$ -1.27$ 0.43$ -1.23$ -2.91$ -3.52
Weighted Average Shares Outstanding
54.04M 52.70M 37.59M 30.90M 22.39M
Weighted Average Shares Outstanding (Diluted)
54.04M 52.99M 37.59M 30.90M 22.39M
Currency in USD

Spero Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis